These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of synthetic colloids in sepsis: a critical review on efficacy, safety and patient benefits. Trof RJ; Groeneveld AB Minerva Anestesiol; 2011 Dec; 77(12):1216-23. PubMed ID: 21666572 [TBL] [Abstract][Full Text] [Related]
25. Advantages and disadvantages of colloid and crystalloid fluids. Pryke S Nurs Times; 2004 Mar 9-15; 100(10):32-3. PubMed ID: 15045778 [TBL] [Abstract][Full Text] [Related]
26. Preferences for colloid use in Scandinavian intensive care units. FLUIDS study investigators for the Scandinavian Critical Care Trials Group Acta Anaesthesiol Scand; 2008 Jul; 52(6):750-8. PubMed ID: 18582303 [TBL] [Abstract][Full Text] [Related]
27. Crystalloids and colloids. A personal view on their perioperative use. Veeckman L Acta Anaesthesiol Belg; 2003; 54(4):323-31. PubMed ID: 14719354 [No Abstract] [Full Text] [Related]
30. Blood transfusion--a review of the literature. Patel KF; Angole YE Med J Zambia; 1978; 11(6):160-3. PubMed ID: 716626 [TBL] [Abstract][Full Text] [Related]
31. Hemorrhagic shock: update in pathophysiology and therapy. Marzi I Acta Anaesthesiol Scand Suppl; 1997; 111():42-4. PubMed ID: 9420950 [No Abstract] [Full Text] [Related]
32. [Effect of correction of deficit of the circulating blood volume in the post-resuscitation period with the aid of various transfusion media]. Podoluzhnaia NV Patol Fiziol Eksp Ter; 1978; (1):33-7. PubMed ID: 643329 [No Abstract] [Full Text] [Related]
34. Contemporary fluid management in cardiac anesthesia. Habicher M; Perrino A; Spies CD; von Heymann C; Wittkowski U; Sander M J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1141-53. PubMed ID: 20947379 [No Abstract] [Full Text] [Related]
35. Clinical trial of six per cent HES in 19 patients. Solanke TF West Afr Med J Niger Pract; 1968 Dec; 17(6):242-3. PubMed ID: 5703586 [No Abstract] [Full Text] [Related]
36. Component therapy of surgical hemorrhage: red cells, plasma substitutes and albumin. Lundsgaard-Hansen P; Pappova E Ann Clin Res; 1981; 13 Suppl 33():26-38. PubMed ID: 7342841 [No Abstract] [Full Text] [Related]
37. [Therapy of hypovolemia in EPH-gestoses using plasma expanders with central venous pressure control]. Lippert TH; Cloeren SE; Hinselmann M Gynakol Rundsch; 1973; 13():Suppl 1:107-8. PubMed ID: 4798924 [No Abstract] [Full Text] [Related]
38. [Blood volume--what brings us to the new millennium?]. Kreimeier U Anaesthesist; 2001 Jun; 50(6):429-31. PubMed ID: 11458725 [No Abstract] [Full Text] [Related]
39. [Effect of various plasma substitutes on circulating blood volume]. KORTH J Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1953; 276():731-3. PubMed ID: 13143874 [No Abstract] [Full Text] [Related]
40. PRESENT STATUS OF PLASMA-EXPANDING AGENTS. GREGERSEN MI Listing Res Cardiovasc Field; 1964; 10():129-30. PubMed ID: 24547391 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]